Wall Street is closing out a strong quarter. Plus, Lilly’s mixed obesity drug trial data

Share

Wall Street wrapped up the third quarter on a strong note, with the S&P 500 rising about 2.6% and the Nasdaq gaining 3%. Top performers for the quarter were Salesforce, CrowdStrike and Microsoft, while FedEx Freight, Home Depot and Qnity Electronics were the biggest laggards. Eli Lilly announced promising mid-stage trial results for EloraTZP, a combination therapy for obesity showing 23.3% weight loss versus 14.8% for tirzepatide alone, though adverse events were more frequent with the combination. Apple gained 2% in the broader tech rally.

Source: Read the original article

Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
Telemac
Telemachttp://cryptoinfo.ch
Passionné de nouvelles technologies, j’explore l’univers de la blockchain et des cryptomonnaies pour partager l’actualité et les innovations du secteur.

Read More

Items